New project started to jointly develop Artilysin(R)s as innovative novel treatment option for infected, chronic wounds such as diabetic foot infections, the most common complication of diabetes mellitusExpansion
a new class of molecules with a novel resistance-breaking mode of action and the potential to replace common antibiotics Artilysins are able to pass the protective outer membrane of Gram-negative.